Lexicon Pharmaceuticals
LXRX
#7398
Rank
โ‚น39.34 B
Marketcap
โ‚น108.27
Share price
-0.82%
Change (1 day)
53.28%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -โ‚น16.40

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น17.00. In 2024 the company made an earnings per share (EPS) of -โ‚น57.26 an increase over its 2023 EPS that were of -โ‚น71.58.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น16.40-71.36%
2024-โ‚น57.26-20%
2023-โ‚น71.5831.15%
2022-โ‚น54.58-0%
2021-โ‚น54.5810.91%
2020-โ‚น49.21-145.08%
2019โ‚น109.16-206.09%
2018-โ‚น102.90-5.74%
2017-โ‚น109.16-10.95%
2016-โ‚น122.582640%
2015-โ‚น4.47-96.34%
2014-โ‚น122.10-2.53%
2013-โ‚น125.27-9.09%
2012-โ‚น137.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
-โ‚น6,864 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น3,887-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น531.49 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น243.37-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น1,552-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น44.74 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น399.96-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น213.85-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น67.11 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA